Drug General Information (ID: DDIG5CZAHB)
Drug Name			Daratumumab		Drug Info		Monomethyl fumarate		Drug Info
Drug Type		Monoclonal antibody				Small molecule
Therapeutic Class		Antineoplastics/Cd38 Monoclonal Antibodies				Selective Immunosuppressants

Mechanism of Daratumumab-Monomethyl fumarate Interaction (Severity Level: Moderate)
Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Drug Name		Daratumumab				Monomethyl fumarate
Mechanism		Immunosuppressive effects				Immunosuppressive effects
Key Mechanism Factor 1
		Factor Name		Immunosuppressive effects
		Factor Description		Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
Mechanism Description		Additive immunosuppressive effects by the combination of Daratumumab and Monomethyl fumarate

Recommended Action
Management		The safety and efficacy of monomethyl fumarate, dimethyl fumarate, or diroximel fumarate in combination with other immunosuppressive or myelosuppressive agents have not been evaluated. Until further information is available, concomitant use should be avoided if possible.

References
1	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.